101
|
Riccardi G. NMCD is growing up: short thoughts on a teenager's life. Nutr Metab Cardiovasc Dis 2003; 13:1. [PMID: 12772431 DOI: 10.1016/s0939-4753(03)80161-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
102
|
Battaglieri M, Brunoldi M, De Vita R, Laget JM, Osipenko M, Ripani M, Taiuti M, Adams G, Amaryan MJ, Anciant E, Anghinolfi M, Armstrong DS, Asavapibhop B, Asryan G, Audit G, Auger T, Avakian H, Barrow S, Beard K, Bektasoglu M, Berman BL, Bersani A, Bianchi N, Biselli AS, Boiarinov S, Bouchigny S, Bradford R, Branford D, Briscoe WJ, Brooks WK, Burkert VD, Calarco JR, Capitani GP, Carman DS, Carnahan B, Cazes A, Cetina C, Cole PL, Coleman A, Cords D, Corvisiero P, Crabb D, Crannell H, Cummings JP, DeSanctis E, Degtyarenko PV, Demirchyan R, Denizli H, Dennis L, Dharmawardane KV, Dhuga KS, Djalali C, Dodge GE, Doughty D, Dragovitsch P, Dugger M, Dytman S, Eckhause M, Egiyan H, Egiyan KS, Elouadrhiri L, Farhi L, Feuerbach RJ, Ficenec J, Forest TA, Freyberger AP, Frolov V, Funsten H, Gaff SJ, Gai M, Garcon M, Gavalian G, Gilad S, Gilfoyle GP, Giovanetti KL, Golovach E, Griffioen K, Guidal M, Guillo M, Guo L, Gyurjyan V, Hadjidakis C, Hancock D, Hardie J, Heddle D, Hersman FW, Hicks K, Hicks RS, Holtrop M, Hyde-Wright CE, Ito MM, Joo K, Kelley JH, Khandaker M, Kim W, Klein A, Klein FJ, Klimenko AV, Klusman M, Kossov M, Kramer LH, Kuang Y, Kuhn SE, Lachniet J, Lawrence D, Lucas M, Lukashin K, Major RW, Manak JJ, Marchand C, McAleer S, McCarthy J, McNabb JWC, Mecking BA, Mestayer MD, Meyer CA, Mikhailov K, Mirazita M, Miskimen R, Mokeev V, Morrow S, Mozer MU, Muccifora V, Mueller J, Mutchler GS, Napolitano J, Nelson SO, Niccolai S, Niczyporuk BB, Niyazov RA, Nozar M, O'Brien JT, Opper AK, Peterson G, Philips SA, Pivnyuk N, Pocanic D, Pogorelko O, Polli E, Preedom BM, Price JW, Protopopescu D, Qin LM, Raue BA, Reolon AR, Riccardi G, Ricco G, Ritchie BG, Ronchetti F, Rossi P, Rowntree D, Rubin PD, Sabourov K, Salgado C, Sapunenko V, Schumacher RA, Serov VS, Shafi A, Sharabian YG, Shaw J, Skabelin AV, Smith ES, Smith T, Smith LC, Sober DI, Spraker M, Stavinsky A, Stepanyan S, Stoler P, Taylor S, Tedeschi DJ, Todor L, Thoma U, Thompson R, Vineyard MF, Vlassov AV, Wang K, Weinstein LB, Weller H, Weygand DP, Whisnant CS, Wolin E, Wood M, Yegneswaran A, Yun J, Zhang B, Zhao J, Zhou Z. Photoproduction of the omega meson on the proton at large momentum transfer. PHYSICAL REVIEW LETTERS 2003; 90:022002. [PMID: 12570539 DOI: 10.1103/physrevlett.90.022002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/08/2002] [Indexed: 05/24/2023]
Abstract
The differential cross section, dsigma/dt, for omega meson exclusive photoproduction on the proton above the resonance region (2.6<W<2.9 GeV) was measured up to a momentum transfer -t=5 GeV2 using the CLAS detector at Jefferson Laboratory. The omega channel was identified by detecting a proton and pi(+) in the final state and using the missing mass technique. While the low momentum transfer region shows the typical diffractive pattern expected from Pomeron and Reggeon exchange, at large -t the differential cross section has a flat behavior. This feature can be explained by introducing quark interchange processes in addition to the QCD-inspired two-gluon exchange.
Collapse
|
103
|
Genovese S, Riccardi G. The role of modulation of GH/IGF-I axis in the development of diabetic proliferative retinopathy. J Endocrinol Invest 2003; 26:114-6. [PMID: 15233225] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 04/19/2023]
|
104
|
Dugger M, Ritchie BG, Ball J, Pasyuk E, Adams G, Anciant E, Anghinolfi M, Asavapibhop B, Audit G, Auger T, Avakian H, Bagdasaryan H, Barrow S, Battaglieri M, Beard K, Bektasoglu M, Bellis M, Berman BL, Bianchi N, Biselli AS, Boiarinov S, Bouchigny S, Bradford R, Branford D, Briscoe WJ, Brooks WK, Burkert VD, Calarco JR, Capitani GP, Carman DS, Carnahan B, Cetina C, Clark R, Cole PL, Coleman A, Connelly J, Cords D, Corvisiero P, Crabb D, Crannell H, Cummings JP, DeSanctis E, DeVita R, Degtyarenko PV, Denizli H, Dennis L, Dharmawardane KV, Dhuga KS, Djalali C, Dodge GE, Doughty D, Dragovitsch P, Dytman S, Eckhause M, Egiyan H, Egiyan KS, Elouadrhiri L, Farhi L, Fatemi R, Feldman G, Feuerbach RJ, Ficenec J, Forest TA, Frolov V, Funsten H, Gaff SJ, Gai M, Gavalian G, Gilad S, Gilfoyle GP, Giovanetti KL, Girard P, Gordon CIO, Griffioen K, Guidal M, Guillo M, Guo L, Gyurjyan V, Hadjidakis C, Hancock D, Hardie J, Heddle D, Heimberg P, Hersman FW, Hicks K, Hicks RS, Holtrop M, Hyde-Wright CE, Ito MM, Jenkins D, Joo K, Kelley JH, Kellie JD, Khandaker M, Kim W, Klein A, Klein FJ, Klusman M, Kossov M, Koubarovski V, Kramer LH, Kuang Y, Kuhn SE, Kuhn J, Lachniet J, Laget JM, Lawrence D, Li J, Livingston K, Longhi A, Lucas M, Lukashin K, Major W, Manak JJ, Marchand C, McAleer S, McCarthy J, McNabb JWC, Mecking BA, Mehrabyan S, Mestayer MD, Meyer CA, Mikhailov K, Minehart R, Mirazita M, Miskimen R, Morand L, Morrow SA, Mozer MU, Muccifora V, Mueller J, Murphy LY, Mutchler GS, Napolitano J, Nasseripour R, Nelson SO, Niccolai S, Niculescu G, Niculescu I, Niczyporuk BB, Niyazov RA, Nozar M, O'Brien JT, O'Rielly GV, Opper AK, Park K, Peterson G, Philips SA, Pivnyuk N, Pocanić D, Pogorelko O, Polli E, Pozdniakov S, Preedom BM, Price JW, Prok Y, Protopopescu D, Qin LM, Raue BA, Riccardi G, Ricco G, Ripani M, Ronchetti F, Rossi P, Rowntree D, Rubin PD, Sabatié F, Sabourov K, Salgado C, Santoro JP, Sanzone-Arenhovel M, Sapunenko V, Schumacher RA, Serov VS, Shafi A, Sharabian YG, Shaw J, Skabelin AV, Smith ES, Smith T, Smith LC, Sober DI, Spraker M, Stavinsky A, Stepanyan S, Stoler P, Strakovsky II, Strauch S, Taiuti M, Taylor S, Tedeschi DJ, Thoma U, Thompson R, Todor L, Ungaro M, Vineyard MF, Vlassov AV, Wang K, Weinstein LB, Weller H, Weygand DP, Whisnant CS, Witkowski M, Wolin E, Wood MH, Yegneswaran A, Yun J, Zhang B, Zhao J, Zhou Z. Eta photoproduction on the proton for photon energies from 0.75 to 1.95 GeV. PHYSICAL REVIEW LETTERS 2002; 89:222002. [PMID: 12485062 DOI: 10.1103/physrevlett.89.222002] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/11/2002] [Indexed: 05/24/2023]
Abstract
Differential cross sections for gammap-->etap have been measured with tagged real photons for incident photon energies from 0.75 to 1.95 GeV. Mesons were identified by missing mass reconstruction using kinematical information for protons scattered in the production process. The data provide the first extensive angular distribution measurements for the process above W=1.75 GeV. Comparison with preliminary results from a constituent quark model support the suggestion that a third S11 resonance with mass approximately 1.8 GeV couples to the etaN channel.
Collapse
|
105
|
Vaccaro O, Mancini FP, Ruffa G, Sabatino L, Iovine C, Masulli M, Colantuoni V, Riccardi G. Fasting plasma free fatty acid concentrations and Pro12Ala polymorphism of the peroxisome proliferator-activated receptor (PPAR) gamma2 gene in healthy individuals. Clin Endocrinol (Oxf) 2002; 57:481-6. [PMID: 12354130 DOI: 10.1046/j.1365-2265.2002.01618.x] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
BACKGROUND The Pro12Ala polymorphism of the peroxisome proliferator-activated receptor (PPAR) gamma gene has been associated in some, but not all, studies with lower body mass index (BMI) and improved insulin sensitivity; how an altered transcriptional activity of PPARgamma2 could influence insulin sensitivity is currently unclear. The free fatty acids (FFAs) released from adipose tissue triglycerides via lipolysis are key mediators of impaired insulin sensitivity; however, no study has described the relationship of the Pro12Ala mutation with circulating levels of FFAs under physiological conditions. OBJECTIVE To investigate in a population-based sample of Caucasians the relation of the Pro12Ala polymorphism with plasma concentrations of FFAs and other markers of lipid and glucose metabolism described as components of the insulin resistance syndrome. SUBJECTS Four hundred and thirty-eight nondiabetic employees of the Italian Telephone Company, aged 35-65 years, randomly selected from a total population of 3900 participants in a company-sponsored health screening. MEASUREMENTS The Pro12Ala polymorphism of the PPARgamma was studied together with plasma FFAs, insulin, glucose, triglycerides, high density lipoprotein (HDL) cholesterol, blood pressure and anthropometry. The Homeostatic Model Assessment (HOMA) index was calculated as a measure of insulin resistance. RESULTS Carriers and noncarriers of the Pro12Ala polymorphism showed very similar circulating levels of FFA (0.46 +/- 0.2 vs. 0.47 +/- 0.2, NS); plasma glucose, triglycerides, HDL cholesterol and blood pressure were also similar in the two groups with or without the polymorphism. To allow for the possible confounding effect of obesity, a separate analysis was conducted in overweight (BMI > or = 25 kg/m(2)) and normal-weight people (BMI < 25 kg/m(2)). Circulating plasma FFA concentrations, as well as triglycerides, blood pressure and HOMA, were significantly higher in overweight than normal-weight, as expected, but no significant differences were detected between carriers and noncarriers of the Pro12Ala polymorphism within each BMI group (0.49 +/- 0.2 vs. 0.48 +/- 0.2, NS, and 0.44 +/- 0.2 vs. 0.47 +/- 0.2, NS, in overweight and normal-weight, respectively). The Pro12Ala polymorphism was also analysed across increasing quartiles of FFA concentrations and no relationship was observed between the frequency of the polymorphism and FFA values (overall chi2 = 0.48, NS). CONCLUSION This study does not show any relationship between the Pro12Ala polymorphism of the PPARgamma gene and fasting FFAs in the general population. The possibility of a different handling of FFAs under different conditions (i.e. postprandial) cannot be excluded and remains to be explored.
Collapse
|
106
|
Abstract
Diabetes is a plurimetabolic disease characterised mainly by glucose metabolism abnormalities that lead to the development of acute and long-term complications. Long-term complications are rapidly increasing, which explains the higher mortality due to cardiovascular events in diabetic patients compared to the general population. A poor blood glucose control is known to be an important risk factor for the development of cardiovascular complications, and dietary fibre - particularly the soluble type - plays an important role in controlling plasma glucose concentrations and other risk factors associated with diabetes. Nevertheless, there are still some doubts as to whether it is possible to achieve, in free-living diabetic patients, good compliance to a high fibre diet without using fibre supplements or foods fortified with fibre, and whether the beneficial effects of this diet on blood glucose control, observed in acute or in medium-term studies, are clinically relevant also in the longterm. Recently, a wealth of convincing evidence has confirmed the hypothesis that, in diabetic patients, dietary fibre decreases postprandial plasma glucose, insulin and triglyceride concentrations, and has a clinically relevant hypocholesterolaemic effect. These data also show that: 1) it is possible to increase dietary fibre by consuming exclusively natural foods, with a satisfactory compliance in free-living diabetic patients also in the long-term, due to its minimal side-effects; and 2) the beneficial metabolic effects of dietary fibre are long-lasting and clinically relevant, as shown by the lower plasma glycosylated haemoglobin levels, reduced rate of hypoglycaemic episodes and improved cardiovascular profile both in type 1 and type 2 diabetic patients.
Collapse
|
107
|
Joo K, Smith LC, Burkert VD, Minehart R, Aznauryan IG, Elouadrhiri L, Stepanyan S, Adams GS, Amaryan MJ, Anciant E, Anghinolfi M, Armstrong DS, Asavapibhop B, Audit G, Auger T, Avakian H, Barrow S, Bagdasaryan H, Battaglieri M, Beard K, Bektasoglu M, Bertozzi W, Bianchi N, Biselli AS, Boiarinov S, Bonner BE, Brooks WK, Calarco JR, Capitani GP, Carman DS, Carnahan B, Cole PL, Coleman A, Cords D, Corvisiero P, Crabb D, Crannell H, Cummings J, De Sanctis E, De Vita R, Degtyarenko PV, Demirchyan RA, Denizli H, Dennis LC, Deppman A, Dharmawardane KV, Dhuga KS, Djalali C, Dodge GE, Doughty D, Dragovitsch P, Dugger M, Dytman S, Eckhause M, Efremenko YV, Egiyan H, Egiyan KS, Farhi L, Feuerbach RJ, Ficenec J, Fissum K, Forest TA, Funsten H, Gai M, Gavrilov VB, Gilad S, Gilfoyle GP, Giovanetti KL, Girard P, Griffioen KA, Guidal M, Guillo M, Gyurjyan V, Hancock D, Hardie J, Heddle D, Heisenberg J, Hersman FW, Hicks K, Hicks RS, Holtrop M, Hyde-Wright CE, Ito MM, Jenkins D, Kelley JH, Khandaker M, Kim KY, Kim W, Klein A, Klein FJ, Klusman M, Kossov M, Kuang Y, Kuhn SE, Laget JM, Lawrence D, Longhi A, Loukachine K, Lucas M, Major RW, Manak JJ, Marchand C, Matthews SK, McAleer S, McNabb JWC, Mecking BA, Mestayer MD, Meyer CA, Mirazita M, Miskimen R, Muccifora V, Mueller J, Mutchler GS, Napolitano J, Niculescu G, Niczyporuk B, Niyazov RA, Ohandjanyan MS, Opper A, Patois Y, Peterson GA, Philips S, Pivnyuk N, Pocanic D, Pogorelko O, Polli E, Preedom BM, Price JW, Qin LM, Raue BA, Reolon AR, Riccardi G, Ricco G, Ripani M, Ritchie BG, Ronchetti F, Rossi P, Rowntree D, Rubin PD, Salgado CW, Sanzone M, Sapunenko V, Sargsyan M, Schumacher RA, Sharabian YG, Shaw J, Shuvalov SM, Skabelin A, Smith ES, Smith T, Sober DI, Spraker M, Stoler P, Taiuti M, Taylor S, Tedeschi D, Thompson R, Todor L, Tung TY, Vineyard MF, Vlassov A, Weller H, Weinstein LB, Welsh R, Weygand DP, Whisnant S, Witkowski M, Wolin E, Yegneswaran A, Yun J, Zhou Z, Zhao J. Q2 Dependence of quadrupole strength in the gamma*p --> Delta(+)(1232) --> p pi(0) transition. PHYSICAL REVIEW LETTERS 2002; 88:122001. [PMID: 11909446 DOI: 10.1103/physrevlett.88.122001] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/02/2001] [Indexed: 05/23/2023]
Abstract
Models of baryon structure predict a small quadrupole deformation of the nucleon due to residual tensor forces between quarks or distortions from the pion cloud. Sensitivity to quark versus pion degrees of freedom occurs through the Q2 dependence of the magnetic (M1+), electric (E1+), and scalar (S1+) multipoles in the gamma*p-->Delta(+)-->p pi(0) transition. We report new experimental values for the ratios E(1+)/M(1+) and S(1+)/M(1+) over the range Q2 = 0.4-1.8 GeV2, extracted from precision p(e,e(')p)pi(0) data using a truncated multipole expansion. Results are best described by recent unitary models in which the pion cloud plays a dominant role.
Collapse
|
108
|
De Vita R, Anghinolfi M, Burkert VD, Dodge GE, Minehart R, Taiuti M, Weller H, Adams G, Amaryan MJ, Anciant E, Armstrong DS, Asavapibhop B, Asryan G, Audit G, Auger T, Avakian H, Bagdasaryan H, Ball JP, Barrow S, Battaglieri M, Beard K, Bektasoglu M, Bianchi N, Biselli AS, Boiarinov S, Bonner BE, Bosted P, Bouchigny S, Branford D, Brooks WK, Bueltmann S, Calarco JR, Capitani GP, Carman DS, Carnahan B, Cazes A, Ciciani L, Cole PL, Coleman A, Connelly J, Cords D, Corvisiero P, Crabb D, Crannell H, Cummings JP, De Sanctis E, Degtyarenko PV, Demirchyan R, Denizli H, Dennis L, Dharmawardane KV, Dhuga KS, Djalali C, Doughty D, Dragovitsch P, Dugger M, Dytman S, Eckhause M, Egiyan H, Egiyan KS, Elouadrhiri L, Empl A, Farhi L, Fatemi R, Feuerbach RJ, Ficenec J, Forest TA, Frolov V, Funsten H, Gaff SJ, Gai M, Garçon M, Gavalian G, Gilad S, Gilfoyle GP, Giovanetti KL, Girard P, Golovatch E, Griffioen K, Guidal M, Guillo M, Gyurjyan V, Hadjidakis C, Hancock D, Hardie J, Heddle D, Heimberg P, Hersman FW, Hicks K, Hicks RS, Holtrop M, Hu J, Hyde-Wright CE, Ishkanov BS, Ito MM, Jenkins D, Joo K, Kelley JH, Kellie JD, Khandaker M, Kim KY, Kim K, Kim W, Klein A, Klein FJ, Klusman M, Kossov M, Kramer LH, Kuang Y, Kuhn SE, Lachniet J, Laget JM, Lawrence D, Li J, Livingston K, Longhi A, Loukachine K, Lucas M, Major W, Manak JJ, Marchand C, McAleer S, McCarthy J, McNabb JWC, Mecking BA, Mestayer MD, Meyer CA, Mikhailov K, Mirazita M, Miskimen R, Mokeev V, Muccifora V, Mueller J, Mutchler GS, Napolitano J, Nelson SO, Niculescu G, Niculescu I, Niczyporuk BB, Niyazov RA, Opper AK, O'Rielly GV, Osipenko M, Park K, Pasyuk E, Peterson G, Philips SA, Pivnyuk N, Pocanic D, Pogorelko O, Polli E, Pozdniakov S, Preedom BM, Price JW, Prok Y, Protopopescu D, Qin LM, Raue BA, Reolon AR, Riccardi G, Ricco G, Ripani M, Ritchie BG, Rock S, Ronchetti F, Rossi P, Rowntree D, Rubin PD, Sabatié F, Sabourov K, Salgado C, Sapunenko V, Sargsyan M, Schumacher RA, Serov VS, Shafi A, Sharabian YG, Shaw J, Skabelin AV, Smith ES, Smith T, Smith LC, Sober DI, Sorrell L, Spraker M, Stavinsky A, Stepanyan S, Stoler P, Strakovsky II, Taylor S, Tedeschi DJ, Thompson R, Todor L, Ungaro M, Vineyard MF, Vlassov AV, Wang K, Weinstein LB, Weisberg A, Weygand DP, Whisnant CS, Wolin E, Yegneswaran A, Yun J, Zhang B, Zhao J, Zhou Z. First measurement of the double spin asymmetry in (-->)e(-->)p-->e(prime)pi(+)n in the resonance region. PHYSICAL REVIEW LETTERS 2002; 88:082001. [PMID: 11863951 DOI: 10.1103/physrevlett.88.082001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/31/2001] [Indexed: 05/23/2023]
Abstract
The double spin asymmetry in the (-->)e(-->)p --> e(prime)pi(+)n reaction has been measured for the first time in the resonance region for four-momentum transfer Q2 = 0.35-1.5 GeV(2). Data were taken at Jefferson Lab with the CLAS detector using a 2.6 GeV polarized electron beam incident on a polarized solid NH3 target. Comparison with predictions of phenomenological models shows strong sensitivity to resonance contributions. Helicity-1/2 transitions are found to be dominant in the second and third resonance regions. The measured asymmetry is consistent with a faster rise with Q(2) of the helicity asymmetry A1 for the F(15)(1680) resonance than expected from the analysis of the unpolarized data.
Collapse
|
109
|
Milano A, Forti F, Sala C, Riccardi G, Ghisotti D. Transcriptional regulation of furA and katG upon oxidative stress in Mycobacterium smegmatis. J Bacteriol 2001; 183:6801-6. [PMID: 11698368 PMCID: PMC95520 DOI: 10.1128/jb.183.23.6801-6806.2001] [Citation(s) in RCA: 56] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
The DNA region upstream of katG in Mycobacterium smegmatis was cloned and sequenced. The furA gene, highly homologous to Mycobacterium tuberculosis furA, mapped in this region. The furA-katG organization appears to be conserved among several mycobacteria. The transcription pattern of furA and katG in M. smegmatis upon oxidative stress was analyzed by Northern blotting and primer extension. Although transcription of both furA and katG was induced upon oxidative stress, transcripts covering both genes could not be identified either by Northern blotting or by reverse transcriptase PCR. Specific transcripts and 5' ends were identified for furA and katG, respectively. By cloning M. smegmatis and M. tuberculosis DNA regions upstream of a reporter gene, we demonstrated the presence of two promoters, pfurA, located immediately upstream of the furA gene, and pkatG, located within the terminal part of the furA coding sequence. Transcription from pfurA was induced upon oxidative stress. A 23-bp sequence overlapping the pfurA -35 region is highly conserved among mycobacteria and streptomycetes and might be involved in controlling pfurA activity. Transcription from a cloned pkatG, lacking the upstream pfurA region, was not induced upon oxidative stress, suggesting a cis-acting regulatory role of this region.
Collapse
|
110
|
Carbonera D, Sora S, Riccardi G, Camerino G, Ciferri O. Characterization of a mutant of chlamydomonas reinhardtII
resistant to fusidic acid. FEBS Lett 2001. [DOI: 10.1016/0014-5793(81)81166-0] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
111
|
Battaglieri M, Anciant E, Anghinolfi M, De Vita R, Golovach E, Laget JM, Mokeev V, Ripani M, Adams G, Amaryan MJ, Armstrong DS, Asavapibhop B, Asryan G, Audit G, Auger T, Avakian H, Barrow S, Beard K, Bektasoglu M, Berman BL, Bianchi N, Biselli AS, Boiarinov S, Branford D, Briscoe WJ, Brooks WK, Burkert VD, Calarco JR, Capitani GP, Carman DS, Carnahan B, Cazes A, Cetina C, Cole PL, Coleman A, Cords D, Corvisiero P, Crabb D, Crannell H, Cummings JP, DeSanctis E, Degtyarenko PV, Demirchyan R, Denizli H, Dennis L, Dharmawardane KV, Dhuga KS, Djalali C, Dodge GE, Doughty D, Dragovitsch P, Dugger M, Dytman S, Eckhause M, Egiyan H, Egiyan KS, Elouadrhiri L, Farhi L, Feuerbach RJ, Ficenec J, Forest TA, Freyberger AP, Frolov V, Funsten H, Gaff SJ, Gai M, Gilad S, Gilfoyle GP, Giovanetti KL, Griffioen K, Guidal M, Guillo M, Gyurjyan V, Hancock D, Hardie J, Heddle D, Hersman FW, Hicks K, Hicks RS, Holtrop M, Hyde-Wright CE, Ito MM, Joo K, Kelley JH, Khandaker M, Kim W, Klein A, Klein FJ, Klusman M, Kossov M, Kramer LH, Kuang Y, Kuhn SE, Lawrence D, Lucas M, Lukashin K, Major RW, Manak JJ, Marchand C, McAleer S, McCarthy J, McNabb JW, Mecking BA, Mestayer MD, Meyer CA, Mikhailov K, Minehart R, Mirazita M, Miskimen R, Muccifora V, Mueller J, Mutchler GS, Napolitano J, Nelson SO, Niczyporuk BB, Niyazov RA, O'Brien JT, Opper AK, Peterson G, Philips SA, Pivnyuk N, Pocanic D, Pogorelko O, Polli E, Preedom BM, Price JW, Protopopescu D, Qin LM, Raue BA, Reolon AR, Riccardi G, Ricco G, Ritchie BG, Ronchetti F, Rossi P, Rowntree D, Rubin PD, Sabourov K, Salgado C, Sanzone-Arenhovel M, Sapunenko V, Schumacher RA, Serov VS, Shafi A, Sharabian YG, Shaw J, Skabelin AV, Smith ES, Smith T, Smith LC, Sober DI, Spraker M, Stavinsky A, Stepanyan S, Stoler P, Taiuti M, Taylor S, Tedeschi DJ, Todor L, Thompson R, Vineyard MF, Vlassov AV, Weinstein LB, Weisberg A, Weller H, Weygand DP, Whisnant CS, Wolin E, Wood M, Yegneswaran A, Yun J, Zhang B, Zhao J, Zhou Z. Photoproduction of the rho(0) meson on the proton at large momentum transfer. PHYSICAL REVIEW LETTERS 2001; 87:172002. [PMID: 11690264 DOI: 10.1103/physrevlett.87.172002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/10/2001] [Indexed: 05/23/2023]
Abstract
The differential cross section, d sigma/dt, for rho(0) meson photoproduction on the proton above the resonance region was measured up to a momentum transfer -t = 5 GeV2 using the CLAS detector at the Thomas Jefferson National Accelerator Facility. The rho(0) channel was extracted from the measured two charged-pion cross sections by fitting the pi(+)pi(-) and p pi(+) invariant masses. The low momentum transfer region shows the typical diffractive pattern expected from Reggeon exchange. The flatter behavior at large -t cannot be explained solely in terms of QCD-inspired two-gluon exchange models. The data indicate that other processes, like quark interchange, are important to fully describe rho photoproduction.
Collapse
|
112
|
Annuzzi G, Del Prato S, Arcari R, Bellomo Damato A, Benzi L, Bruttomesso D, Calderini MC, Coscelli C, Fedele D, Galluzzo A, Giordano M, Giorgino R, Lapolla A, Orsini P, Pagano G, Santoro D, Riccardi G. Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type 1 diabetic patients: a multicenter randomized crossover trial. Nutr Metab Cardiovasc Dis 2001; 11:168-175. [PMID: 11590992] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/21/2023]
Abstract
BACKGROUND AND AIM While lispro insulin has been reported to lower postprandial blood glucose concentrations, less consistent effects have been shown for glycosylated hemoglobin (HbA1c) levels. Aim of this study was to determine whether pre-meal association of NPH, an intermediate-acting insulin, with lispro improves overall glycemic control in type 1 diabetic patients. METHODS AND RESULTS Eighty-five type 1 diabetic patients were studied in a multicenter randomized comparative (human regular vs lispro insulin) crossover (3-month) study in which NPH insulin was given as a dinner or bedtime injection and at breakfast and lunch if necessary. The number of injections was kept constant: 42% and 58% of patients injected insulin 3 and 4 times per day, respectively. Fasting and preprandial blood glucose levels were similar, while postprandial levels improved after lispro compared to human regular insulin (breakfast: 8.28 +/- 2.39 vs 9.28 +/- 2.72 mmol/l; lunch: 8.33 +/- 2.67 vs 9.06 +/- 2.67 mmol/l, dinner: 8.06 +/- 2.72 vs 9.28 +/- 2.44 mmol/l, ANOVA: p = 0.003). HbA1c also improved after lispro: 8.1 +/- 0.9 vs 8.3 +/- 0.8%, p < 0.05. The rate of hypoglycemia was similar. Patients showed better acceptance of lispro treatment (p < 0.001). CONCLUSIONS Lispro improves overall blood glucose control in type 1 diabetic patients without increasing the incidence of hypoglycemia. This can be achieved by an optimal combination of lispro insulin with NPH whenever the time intervals between meals are too long.
Collapse
|
113
|
Kris-Etherton P, Daniels SR, Eckel RH, Engler M, Howard BV, Krauss RM, Lichtenstein AH, Sacks F, St Jeor S, Stampfer M, Grundy SM, Appel LJ, Byers T, Campos H, Cooney G, Denke MA, Kennedy E, Marckmann P, Pearson TA, Riccardi G, Rudel LL, Rudrum M, Stein DT, Tracy RP, Ursin V, Vogel RA, Zock PL, Bazzarre TL, Clark J. AHA scientific statement: summary of the Scientific Conference on Dietary Fatty Acids and Cardiovascular Health. Conference summary from the Nutrition Committee of the American Heart Association. J Nutr 2001; 131:1322-6. [PMID: 11285345 DOI: 10.1093/jn/131.4.1322] [Citation(s) in RCA: 41] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
114
|
Vessby B, Uusitupa M, Hermansen K, Riccardi G, Rivellese AA, Tapsell LC, Nälsén C, Berglund L, Louheranta A, Rasmussen BM, Calvert GD, Maffetone A, Pedersen E, Gustafsson IB, Storlien LH. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia 2001; 44:312-9. [PMID: 11317662 DOI: 10.1007/s001250051620] [Citation(s) in RCA: 711] [Impact Index Per Article: 30.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
AIMS/HYPOTHESIS The amount and quality of fat in the diet could be of importance for development of insulin resistance and related metabolic disorders. Our aim was to determine whether a change in dietary fat quality alone could alter insulin action in humans. METHODS The KANWU study included 162 healthy subjects chosen at random to receive a controlled, isoenergetic diet for 3 months containing either a high proportion of saturated (SAFA diet) or monounsaturated (MUFA diet) fatty acids. Within each group there was a second assignment at random to supplements with fish oil (3.6 g n-3 fatty acids/d) or placebo. RESULTS Insulin sensitivity was significantly impaired on the saturated fatty acid diet (-10%, p = 0.03) but did not change on the monounsaturated fatty acid diet (+2%, NS) (p = 0.05 for difference between diets). Insulin secretion was not affected. The addition of n-3 fatty acids influenced neither insulin sensitivity nor insulin secretion. The favourable effects of substituting a monounsaturated fatty acid diet for a saturated fatty acid diet on insulin sensitivity were only seen at a total fat intake below median (37E%). Here, insulin sensitivity was 12.5% lower and 8.8% higher on the saturated fatty acid diet and monounsaturated fatty acid diet respectively (p = 0.03). Low density lipoprotein cholesterol (LDL) increased on the saturated fatty acid diet (+4.1%, p < 0.01) but decreased on the monounsaturated fatty acid diet (MUFA) (-5.2, p < 0.001), whereas lipoprotein (a) [Lp(a)] increased on a monounsaturated fatty acid diet by 12% (p < 0.001). CONCLUSIONS/INTERPRETATION A change of the proportions of dietary fatty acids, decreasing saturated fatty acid and increasing monounsaturated fatty acid, improves insulin sensitivity but has no effect on insulin secretion. A beneficial impact of the fat quality on insulin sensitivity is not seen in individuals with a high fat intake (> 37E%).
Collapse
|
115
|
Thompson R, Dytman S, Kim KY, Mueller J, Adams GS, Amaryan MJ, Anciant E, Anghinolfi M, Asavapibhop B, Auger T, Audit G, Avakian H, Barrow S, Battaglieri M, Beard K, Bektasoglu M, Bertozzi W, Bianchi N, Biselli A, Boiarinov S, Bonner BE, Briscoe WJ, Brooks W, Burkert VD, Calarco JR, Capitani G, Carman DS, Carnahan B, Cole PL, Coleman A, Connelly J, Cords D, Corvisiero P, Crabb D, Crannell H, Cummings J, Day D, Degtyarenko PV, Demirchyan RA, Dennis LC, Deppman A, De Sanctis E, De Vita R, Dhuga KS, Djalali C, Dodge GE, Doughty D, Dragovitsch P, Dugger M, Eckhause M, Efremenko YV, Egiyan H, Egiyan KS, Elouadrhiri L, Farhi L, Feuerbach RJ, Ficenec J, Fissum K, Freyberger A, Funsten H, Gai M, Gavrilov VB, Gilfoyle GP, Giovanetti K, Gilad S, Girard P, Griffioen KA, Guidal M, Guillo M, Gyurjyan V, Hancock D, Hardie J, Heddle D, Heisenberg J, Hersman FW, Hicks K, Hicks RS, Holtrop M, Hyde-Wright CE, Ito MM, Jenkins D, Joo K, Kane J, Khandaker M, Kim W, Klein A, Klein FJ, Klusman M, Kossov M, Kuhn SE, Kuang Y, Laget JM, Lawrence D, Leskin GA, Longhi A, Loukachine K, Lucas M, Magahiz R, Major RW, Manak JJ, Marchand C, Matthews SK, McAleer S, McCarthy J, McNabb JW, Mecking BA, Mestayer MD, Meyer CA, Minehart R, Mirazita M, Miskimen R, Muccifora V, Mutchler GS, Napolitano J, Niyazov RA, Ohandjanyan MS, O'Brien JT, Opper A, Patois Y, Peterson GA, Philips S, Pivnyuk N, Pocanic D, Pogorelko O, Polli E, Preedom BM, Price JW, Qin LM, Raue BA, Reolon AR, Riccardi G, Ricco G, Ripani M, Ritchie BG, Ronchetti F, Rossi P, Roudot F, Rowntree D, Rubin PD, Salgado CW, Sanzone M, Sapunenko V, Sarty A, Sargsyan M, Schumacher RA, Shafi A, Sharabian YG, Shaw J, Shuvalov SM, Skabelin A, Smith T, Smith C, Smith ES, Sober DI, Spraker M, Stepanyan S, Stoler P, Taiuti M, Taylor S, Tedeschi D, Tung TY, Vineyard MF, Vlassov A, Weller H, Weinstein LB, Welsh R, Weygand DP, Whisnant S, Witkowski M, Wolin E, Yegneswaran A, Yun J, Zhou Z, Zhao J. The ep -->e'p eta reaction at and above the S11(1535) baryon resonance. PHYSICAL REVIEW LETTERS 2001; 86:1702-1706. [PMID: 11290228 DOI: 10.1103/physrevlett.86.1702] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/08/2000] [Indexed: 05/23/2023]
Abstract
New cross sections for the reaction e p-->e p eta are reported for total center of mass energy W = 1.5--1.86 GeV and invariant momentum transfer Q2 = 0.25--1.5 (GeV/c)(2). This large kinematic range allows extraction of important new information about response functions, photocouplings, and eta N coupling strengths of baryon resonances. Newly observed structure at W approximately 1.65 GeV is shown to come from interference between S and P waves and can be interpreted with known resonances. Improved values are derived for the photon coupling amplitude for the S11(1535) resonance.
Collapse
|
116
|
Kris-Etherton P, Daniels SR, Eckel RH, Engler M, Howard BV, Krauss RM, Lichtenstein AH, Sacks F, St Jeor S, Stampfer M, Eckel RH, Grundy SM, Appel LJ, Byers T, Campos H, Cooney G, Denke MA, Howard BV, Kennedy E, Krauss RM, Kris-Etherton P, Lichtenstein AH, Marckmann P, Pearson TA, Riccardi G, Rudel LL, Rudrum M, Sacks F, Stein DT, Tracy RP, Ursin V, Vogel RA, Zock PL, Bazzarre TL, Clark J. Summary of the scientific conference on dietary fatty acids and cardiovascular health: conference summary from the nutrition committee of the American Heart Association. Circulation 2001; 103:1034-9. [PMID: 11181482 DOI: 10.1161/01.cir.103.7.1034] [Citation(s) in RCA: 102] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
117
|
Annuzzi G, Iovine C, Mandarino B, Patti L, Di Marino L, Riccardi G, Rivellese AA. Effect of acute exogenous hyperinsulinaemia on very low density lipoprotein subfraction composition in normal subjects. Eur J Clin Invest 2001; 31:118-24. [PMID: 11168449 DOI: 10.1046/j.1365-2362.2001.00779.x] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Subtle abnormalities of very-low-density lipoprotein (VLDL) composition and distribution seem to be associated with increased cardiovascular risk. The aims of this study were first, to evaluate whether hyperinsulinaemia per se is able to produce VLDL abnormalities and second, whether this occurs through a stimulation of lipolytic enzymes. Eight normal male volunteers, age 36 +/- 7 years (M +/- SD), body mass index (BMI) 26+/-3 kg m-2, underwent a 5-h euglycaemic hyperinsulinaemic clamp (1.2 mU insulin/kg b.w. min-1). Nine sex, age and BMI comparable subjects underwent control experiments (saline infusion). Three VLDL subfractions of decreasing size were isolated by density gradient ultracentrifugation; lipoprotein lipase (LPL) and hepatic lipase (HL) post-heparin plasma activities were determined by the 3H-labelled triolein method. Hyperinsulinaemia ( approximately 65 mU mL-1) produced the expected plasma free fatty acid suppression. Triglyceride levels were reduced in total VLDL (- 27 +/- 32% vs. + 38 +/- 52% after saline, P < 0.05) and in the larger VLDL (- 56 +/- 19 vs. + 34 +/- 38, P < 0.001). Moreover the relative contribution of the larger subfraction was decreased (- 39 +/- 15% vs. - 3 +/- 21%, P < 0.01), while the percentage of smaller particles was increased (+17 +/- 20 vs. - 9 +/- 22, P < 0.05). LPL and HL activities were decreased to the same degree during either insulin or saline infusion. Exogenous hyperinsulinaemia produced lipoprotein abnormalities partially similar to those previously shown in type 1 diabetic patients, indicating that these abnormalities may be secondary to insulin therapy.
Collapse
|
118
|
Giacco R, Brighenti F, Parillo M, Capuano M, Ciardullo AV, Rivieccio A, Rivellese AA, Riccardi G. Characteristics of some wheat-based foods of the Italian diet in relation to their influence on postprandial glucose metabolism in patients with type 2 diabetes. Br J Nutr 2001; 85:33-40. [PMID: 11227031 DOI: 10.1079/bjn2000218] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
The present study was aimed at evaluating in patients with type 2 diabetes: (1) the glycaemic response to four starchy foods based on wheat, typical of the Italian diet; (2) the importance of some food characteristics in relation to their effects on postprandial glucose response. Seventeen patients with type 2 diabetes (eleven men and six women) participated in the study. All patients consumed, in random order and on alternate days, 50 g available carbohydrate provided by 90 g white bread and, according to a randomised procedure, an equivalent amount of carbohydrate provided by one (n 8) or two (n 9) of three other different test foods (g): pizza 85, potato dumplings 165, hard toasted bread 60. Foods had a similar nutrient composition. Plasma glucose response, measured for 180 min, was significantly lower after the potato dumplings than after white bread at 90 (P < 0.05), 120 (P < 0.01), and 150 (P < 0.05) min. No difference was observed in postprandial plasma insulin response after the various test foods. The percentage of starch hydrolysed after 5 h in vitro hydrolysis with alpha-amylase was about 30 % lower for potato dumplings than for the other foods. However, no differences in the resistant starch content, the rate of diffusion of simple sugars added to a dialysis tube containing the food, and the viscosity of digesta were observed among the test foods. Scanning electron microscopy of potato dumplings showed a compact structure compatible with impaired accessibility of starch to digestive enzymes. In conclusion, carbohydrate-rich foods typical of the Italian diet which are often consumed as an alternative to pasta dishes are not equivalent in terms of metabolic impact in diabetic patients. Due to their low blood glucose response, potato dumplings represent a valid alternative to other starchy foods in the diabetic diet. Food structure plays an important role in determining starch accessibility to digestion, thus influencing the postprandial blood glucose response.
Collapse
|
119
|
Sander P, De Rossi E, Böddinghaus B, Cantoni R, Branzoni M, Böttger EC, Takiff H, Rodriquez R, Lopez G, Riccardi G. Contribution of the multidrug efflux pump LfrA to innate mycobacterial drug resistance. FEMS Microbiol Lett 2000; 193:19-23. [PMID: 11094273 DOI: 10.1111/j.1574-6968.2000.tb09396.x] [Citation(s) in RCA: 45] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
Abstract
Multidrug resistance (MDR) in bacteria has been associated with efflux pumps that export structurally unrelated compounds and decrease cytoplasmic drug accumulation. To investigate MDR in mycobacteria, we studied the Mycobacterium smegmatis mutant mc(2)11, which is resistant to doxorubicin, tetracycline, rhodamine, ethidium bromide and the hydrophilic fluoroquinolones. A genomic library constructed from this mutant was used to select clones conferring resistance to doxorubicin. Surprisingly, the clone selected encodes the efflux pump LfrA, which has been reported to confer resistance to hydrophilic fluoroquinolones, ethidium bromide, rhodamine, and acriflavine. To define the contribution of LfrA to the innate mycobacterial drug resistance and to the MDR phenotype in mc(2)11, the lfrA gene was disrupted in both the mc(2)11 mutant and the mc(2)155 wild-type parent. LfrA disruption of the wild-type strain decreased resistance to ethidium bromide and acriflavine, and increased accumulation of ethidium bromide. However, disruption of lfrA gene results only in a 2-fold decrease in minimal inhibitory concentrations (MICs) for ciprofloxacin, doxorubicin, rhodamine, and accumulation of [(14)C]ciprofloxacin was unchanged. LfrA disruption of the MDR strain mc(2)11 produced a similar phenotype. Thus, LfrA contributes significantly to the intrinsic MICs of M. smegmatis for ethidium bromide and acriflavine, but not for ciprofloxacin, doxorubicin or rhodamine.
Collapse
|
120
|
Vaccaro O, Perna AF, Mancini FP, Iovine C, Cuomo V, Sacco M, Tufano A, Rivellese AA, Ingrosso D, Riccardi G. Plasma homocysteine and microvascular complications in type 1 diabetes. Nutr Metab Cardiovasc Dis 2000; 10:297-304. [PMID: 11302003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
Abstract
BACKGROUND Homocysteine is involved in a complex and dynamic system of vascular injury and repair and may thus contribute to the development of diabetic microangiopathy. This still debated issue has important scientific and clinical implications, since hyperhomocysteinemia can be corrected nutritionally. AIMS 1) To evaluate the association between fasting plasma homocysteine, type 1 diabetes and its microvascular complications; 2) to elucidate the basis of this association by investigating the major determinants of plasma homocysteine in relation to diabetic microangiopathy. METHODS We studied sixty-six consecutive patients with type 1 diabetes mellitus of > 10 years duration and normal serum creatinine (< 115 mumol/L, 1.3 mg/dL), and free from clinically detectable cardiovascular diseases. Forty-four non-diabetic controls were also studied. Plasma concentrations of homocysteine, folate and vitamin B12 were investigated together with the C677T mutation in the gene coding for methylenetetrahydrofolate reductase (MTHFR), a key enzyme in homocysteine metabolism. Renal and retinal diabetic complications were evaluated as albumin/creatinine ratio on early-morning, urine spot collection and fundus photographs. FINDINGS Fasting plasma homocysteine levels were very similar in patients and controls. Patients with microalbuminuria or proliferative retinopathy had significantly higher values than those without: 9.4 +/- 3.1 vs 7.4 +/- 2.8 mumol/L, p < 0.02 and 9.5 +/- 2.6 vs 7.3 +/- 3.0 mumol/L, p < 0.05. This difference was not attributable to confounders, such as age, sex and smoking, nor to dissimilar plasma folate and vitamin B12 concentrations. In contrast, homozygosity for the C677T mutation in the MTHFR gene--the commonest genetic defect linked to moderately increased plasma homocysteine--was significantly more frequent in patients with microalbuminuria and/or proliferative retinopathy (50% vs 13%, p < 0.004), odds ratio 6.7 (95% CI 1.7-27.6). CONCLUSIONS Type 1 diabetes as such is not associated with increased plasma homocysteine levels, though patients with microalbuminuria and/or proliferative retinopathy display significantly higher values than those without. This difference is not attributable to obvious confounders, nor to differences in vitamin status, and may be partly mediated by genetic factors. Plasma homocysteine, together with other diabetes-related noxae, may thus be in a position to contribute to the development of nephropathy and the progression of retinopathy.
Collapse
|
121
|
Murphy L, Mutchler GS, Napolitano J, Niyazov RA, Opper A, O'Brien JT, Philips S, Pivnyuk N, Pocanic D, Pogorelko O, Polli E, Preedom BM, Price JW, Qin LM, Raue BA, Reolon AR, Riccardi G, Ricco G, Ripani M, Ritchie BG, Ronchetti F, Rossi P, Roudot F, Rowntree D, Rubin PD, Salgado CW. Photoproduction of straight phi(1020) mesons on the proton at large momentum transfer. PHYSICAL REVIEW LETTERS 2000; 85:4682-4686. [PMID: 11082626 DOI: 10.1103/physrevlett.85.4682] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/16/2000] [Indexed: 05/23/2023]
Abstract
The cross section for straight phi meson photoproduction on the proton has been measured for the first time up to a four-momentum transfer -t = 4 GeV2, using the CLAS detector at the Thomas Jefferson National Accelerator Facility. At low four-momentum transfer, the differential cross section is well described by Pomeron exchange. At large four-momentum transfer, above -t = 1.8 GeV2, the data support a model where the Pomeron is resolved into its simplest component, two gluons, which may couple to any quark in the proton and in the straight phi.
Collapse
|
122
|
Rivellese AA, Patti L, Romano G, Innelli F, Di Marino L, Annuzzi G, Iavicoli M, Coronel GA, Riccardi G. Effect of insulin and sulfonylurea therapy, at the same level of blood glucose control, on low density lipoprotein subfractions in type 2 diabetic patients. J Clin Endocrinol Metab 2000; 85:4188-92. [PMID: 11095452 DOI: 10.1210/jcem.85.11.6956] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
The aim of this study was to evaluate the effect of sc insulin (INS) compared with sulfonylurea (SUL) therapy, at the same level of blood glucose control, on the low density lipoprotein (LDL) subfraction profile in normolipidemic type 2 diabetic patients. Nine normolipidemic type 2 diabetic men (age, 56+/-3 yr; body mass index, 26.5+/-0.9 kg/m2; mean +/- SEM), after a 3-week wash-out period, were assigned to INS or SUL for 2 months in a randomized cross-over design. Doses were adjusted only during the first month and then were kept constant. At the end of the treatments, hemoglobin A1c, plasma lipids, LDL, and very low density lipoprotein (VLDL) subfraction profiles and plasma postheparin lipoprotein lipase and hepatic lipase (HL) activities were evaluated. Despite glucose control was similar at the end of both periods (hemoglobin A1c, 7.4+/-0.3% vs. 7.0+/-0.2%, INS vs. SUL), INS compared with SUL significantly reduced plasma triglyceride (0.9+/-0.1 vs. 1.1+/-0.1 mmol/L; P < 0.05). Although INS did not affect the LDL concentration, it induced a decrease in both the amount (59.0 = 9.8 vs. 76.1+/-16.8 mg/dL; P = NS) and the proportion (31.2+/-3.0% vs. 38.3+/-3.8%; P < 0.03) of small LDL. Moreover, the decrease in small LDL was positively related to the reduction of large VLDL (r = 0.67; P < 0.04) and HL (r = 0.69, P < 0.05) induced by insulin therapy. In conclusion, sc insulin therapy, independently of glucose control and even in the presence of quite low plasma triglyceride levels, is able to reduce small LDL particles in type 2 diabetic patients. This change is related to decreases in both HL activity and large VLDL particles.
Collapse
|
123
|
Giacco R, Parillo M, Rivellese AA, Lasorella G, Giacco A, D'Episcopo L, Riccardi G. Long-term dietary treatment with increased amounts of fiber-rich low-glycemic index natural foods improves blood glucose control and reduces the number of hypoglycemic events in type 1 diabetic patients. Diabetes Care 2000; 23:1461-6. [PMID: 11023137 DOI: 10.2337/diacare.23.10.1461] [Citation(s) in RCA: 198] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
OBJECTIVE To evaluate in type 1 diabetic patients 1) the long-term feasibility of a high-fiber (HF) diet composed exclusively of natural foodstuffs and 2) the efficacy of this diet in relation to blood glucose control and incidence of hypoglycemic episodes. RESEARCH DESIGN AND METHODS The study was randomized with parallel groups. Participants were part of a larger multicenter study on the effects of acarbose on glucose control in diabetes. A total of 63 type 1 diabetic patients, age 28 +/- 9 years, BMI 24 +/- 0.6 kg/m2, after a 4-week run-in period on their habitual diet, were randomized to either an HF (n = 32) or a low-fiber (LF) diet (n = 31) for 24 weeks. The two diets, composed exclusively of natural foodstuffs, were weight-maintaining and, aside from their fiber content, were similar for all nutrients. At the end of the run-in period and the dietary treatment, fasting blood samples for the measurement of plasma cholesterol, HDL cholesterol, triglyceride, and HbA(1c) were collected. A daily glycemic profile was performed on a day in which the participants had consumed a standard menu representative of their treatment diet (HF or LF). RESULTS Of the 63 study subjects, 29 in the HF group (91%) and 25 in the LF group (81%) completed the study Compared with the LF diet, the HF diet after 24 weeks decreased both mean daily blood glucose concentrations (P < 0.05) and number of hypoglycemic events (P < 0.01). When compliance to diet was taken into account, 83% of the subjects on the HF diet and 88% on the LF diet were compliant. In this subgroup, compared with the LF diet, the HF diet significantly reduced mean daily blood glucose concentrations (P < 0.001), HbA(1c) (P < 0.05), and number of hypoglycemic events (P < 0.01). CONCLUSIONS In type 1 diabetic patients, an HF diet is feasible in the long term and, compared with an LF diet, improves glycemic control and reduces the number of hypoglycemic events.
Collapse
|
124
|
Di Marino L, Maffettone A, Cipriano P, Sacco M, Di Palma R, Amato B, Quarto G, Riccardi G, Rivellese AA. Is the erythrocyte membrane fatty acid composition a valid index of skeletal muscle membrane fatty acid composition? Metabolism 2000; 49:1164-6. [PMID: 11016898 DOI: 10.1053/meta.2000.8616] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Recent studies suggest that insulin sensitivity is related to the fatty acid composition of phospholipids in skeletal muscle (SM) membranes. Since it is difficult to obtain muscle biopsies, it may be useful to have information on the fatty acid composition using more accessible cells such as erythrocytes. This would be possible only if the composition of erythrocyte and muscle membranes are very similar. Since no comparative data are available, we evaluated the phospholipid fatty acid composition of erythrocyte and SM membranes in 16 individuals, 10 nondiabetics (male to female ratio, 4:6; age, 50 +/- 11 years; body mass index, 27 +/- 5 kg/m2; mean +/- SD) and 6 type 2 diabetic patients (male to female ratio, 2:4; age, 64 +/- 5 years; body mass index, 27 +/- 4 kg/m2). All patients underwent abdominal surgery, during which a biopsy of the abdominal rectus muscle (50 to 100 mg) was obtained. Erythrocyte and SM phospholipid fatty acids were extracted and then methylated; the methyl fatty acids were separated and quantified by gas chromatography. Compared with erythrocyte membranes, muscle membranes showed a significantly higher proportion of omega-6 polyunsaturated fatty acid ([PUFA] 43.0% +/- 3.1% v29.7% +/- 1.6%, P < .001) and lower saturated fatty acid ([SFA] 41.1% +/- 1.5% v 43.4% +/- 1.2%, P < .001), monounsaturated fatty acid ([MUFA] 11.5% +/- 1.7% v 20.0% +/- 1.9%, P < .001), and omega-3 PUFA (3.8% +/- 0.6% v 7.4% +/- 1.0%, P < .001). The greatest increase involved linoleic acid (26.9% +/- 2.8% v 10.3% +/- 1.6%, P < .001), whereas lignoceric acid (0.8% +/- 0.2% v 5.0% +/- 0.6%, P < .001) and oleic acid (10.4% +/- 1.6% v 13.5% +/- 1.3%, P < .001) were significantly lower. These results show that erythrocyte and muscle membrane phospholipid fatty acids are significantly different. Therefore, data on SM membranes cannot be extrapolated on the basis of measures of erythrocyte phospholipid fatty acid composition.
Collapse
|
125
|
Vaccaro O, Mancini FP, Ruffa G, Sabatino L, Colantuoni V, Riccardi G. Pro12Ala mutation in the peroxisome proliferator-activated receptor gamma2 (PPARgamma2) and severe obesity: a case-control study. Int J Obes (Lond) 2000; 24:1195-9. [PMID: 11033990 DOI: 10.1038/sj.ijo.0801366] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
OBJECTIVE To explore the association of the Pro12Ala mutation in the peroxisome proliferator-activated receptor gamma2 with severe obesity and the features of the metabolic syndrome in a population-based sample of Caucasians. PARTICIPANTS AND METHODS The study is based on a case-control design: 95 non-diabetic severely obese (body mass index, BMI > 35 kg/m2) cases and 280 normal weight (BMI < 25 kg/m2), age- and sex-matched controls selected from the same population were studied. Height, weight, waist circumference, as well as blood pressure were measured according to a standard protocol. BMI at age 25 y was calculated on the basis of current height and reported weight at age 25 y Biochemical measurements included fasting glucose, triglycerides, high-density lipoprotein cholesterol and insulin. DNA analysis was conducted by PCR and gel electrophoresis. RESULTS Age and gender distribution were similar in obese and normal weight participants. The percentage of people with the Pro12Ala mutation was not significantly different in obese or normal weight participants (20% and 15%, respectively; P = 0.32). Conversely, in obese participants with obesity starting in early adulthood (ie with BMI at age 25 above 26.9kg/m2 which represents the median of the whole obese group), the Pro12Ala mutation was observed significantly more frequently than in the normal weight controls (29% vs 15%; chi square = 4.5, P < 0.05; odds ratio 2.4; 95% CI 1.03-5.36). No association of the Pro12Ala variant with any of the component of the metabolic syndrome measured in the study was observed in either obese, juvenile obese or normal weight participants. CONCLUSIONS Results of this study indicate that the Pro12Ala mutation does not play a major role as a determinant of severe obesity and/or features of the metabolic syndrome in the general population. However, this mutation may be of greater importance as a contributor to early onset obesity.
Collapse
|